Earnings History Data for ZIOPHARM Oncology Inc (ZIOP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ZIOPHARM Oncology Inc

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2021	AH	4:00 PM ET (Nov 8)	ZIOP	ZIOPHARM Oncology Inc	353.52	-0.11	-0.15	-0.10	ZIOPHARM Oncology EPS beats by $0.02 [11/8/2021 4:44 PM]	1.60	-0.03 (-1.84%)	1.61	-0.02 (-1.23%)	1.26 - 5.95	2,120,759	1,580,000	7,088
ZIOPHARM Oncology EPS beats by $0.02 [11/8/2021 4:44 PM] Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-08-21 04:10PM] Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting [Nov-09-21 08:05AM]
13-08-2021	PM	4:00 PM ET (Aug 9)	ZIOP	ZIOPHARM Oncology Inc	497.86	-0.11	-0.14	-0.09	ZIOPHARM Oncology reports Q2 results [8/10/2021 8:33 AM]	1.92	-0.37 (-16.16%)	1.92	0.0 (0.00%)	1.83 - 5.95	5,342,886	1,240,000	388
ZIOPHARM Oncology reports Q2 results [8/10/2021 8:33 AM] ZIOPHARM down 11% on Q2 2021 earnings results, analyst downgrade [8/10/2021 10:57 AM] Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates [Aug-09-21 04:05PM] ZIOPHARM Oncology Inc (ZIOP) Q2 2021 Earnings Call Transcript [Aug-10-21 12:30AM]
06-05-2021	AH	4:05 PM ET (May 6)	ZIOP	ZIOPHARM Oncology Inc	675.74	-0.10	-0.11	-0.09	ZIOPHARM Oncology EPS beats by $0.01 [5/6/2021 4:06 PM]	3.20	0.21 (7.02%)	3.20	0.0 (0.00%)	2.06 - 5.95	1,653,892	1,420,000	37,234
ZIOPHARM Oncology EPS beats by $0.01 [5/6/2021 4:06 PM] ZIOPHARM Oncology, Inc. to Host Earnings Call [May-06-21 02:45PM] Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates [May-06-21 04:02PM] Ziopharm Oncology Inc (ZIOP) Q1 2021 Earnings Call Transcript [May-07-21 12:30PM]
25-02-2021	AH	4:00 PM ET (Feb 25)	ZIOP	ZIOPHARM Oncology Inc	1,010	-0.11	-0.10	-0.09	ZIOPHARM Oncology EPS misses by $0.01 [2/25/2021 4:27 PM]	5.35	0.70 (15.05%)	4.80	0.15 (3.23%)	1.80 - 5.95	5,949,674	2,393,149	43,213
ZIOPHARM Oncology EPS misses by $0.01 [2/25/2021 4:27 PM] Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-25-21 04:05PM] ZIOPHARM Oncology, Inc. to Host Earnings Call [Feb-25-21 02:30PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	ZIOP	ZIOPHARM Oncology Inc	483.98	-0.10	-0.09	-0.07	ZIOPHARM Oncology EPS misses by $0.01 [11/5/2020 4:06 PM]	2.22	-0.20 (-8.06%)	2.52	0.10 (4.13%)	1.80 - 5.60	1,135,888	1,604,944	1,200

06-08-2020	AH	4:05 PM ET (Aug 6)	ZIOP	ZIOPHARM Oncology Inc	681.43	-0.09	-0.10	-0.09	ZIOPHARM Oncology EPS in-line [8/6/2020 4:20 PM]	3.37	0.17 (5.29%)	3.09	-0.11 (-3.44%)	1.80 - 6.29	1,073,694	1,246,336	3,835